MetrioPharm Investor Relations News Update
MetrioPharm in the Media
Dear Shareholders
We are very pleased to inform you today that MetrioPharm AG was able to secure two prime time slots in German television coverage, at the end of February 2021.
The "ARD Mittagsmagazin" focused their piece, broadcast on Feb. 26, 2021, on the necessity of therapeutics in the Corona pandemic fight and placed MetrioPharm AG very prominently. You can find the link here, the news piece starts at minute 15:26.
The "Berliner Abendschau" of RBB featured our compound MP1032 and the possible use in acute disease of patients with Covid-19. The link can be found here. (Available until Feb. 28, 2021).
We also like to keep you updated on LinkedIn and would be happy if you followed our account.
Sincerely,
Your MetrioPharm Team
Your contact:
|
|
|
| Eva Brysch Head of Investor Relations & Corporate Communications Phone: +49-(0)30-3384-395-40 Mail: invest@metriopharm.com |
Download